Merck, 1A00160-25MG, Decarboxy Levofloxacin

Name: Decarboxy Levofloxacin
Brand: Merck
SKU: 1A00160-25MG

Size:25 mg, (S)-9-fluoro-3-methyl-7-oxo-10-(4-methylpiperazine-1-yl)-2, 3-dihydro-7H-pyrido [1, 2, 3-de] -1, 4-benzoxazine), Pharmaceutical Analytical Impurity (PAI)

Catalog Number: 1A00160-25MG

Pricing

Send an RFQ.

View RFQ List

Category

Pharmaceutical Reference Standards

Pack Size25 mg

TagsAnalytical Chemistry Reference Materials Pharma Standards

CollectionsMerck Certified Reference Materials: CRMs for Calibration, QC & Instrument Validation Merck Cell Culture Supplements & Reagents: Complete Solutions for Research & Bioproduction Merck Roche Life Science Products for PCR, RT‑PCR & Nucleic Acid Purification

Description

General description
Decarboxy Levofloxacin is a USP Pharmaceutical Analytical Impurity (PAI).
USP PAI are a product line of impurities suitable for research and analytical purposes, which help to ensure the quality and safety of medicines.
Associated Drug Substance: Levofloxacin
Therapeutic Area: Antibiotics
Application
Decarboxy Levofloxacin (USP PAI) is intended for use in analytical testing to detect, identify, and measure pharmaceutical impurities.
Features and Benefits
USP PAI advance your early analytical R&D and process development. PAI can be used in the following applications:
1. Conduct analytical tests during early formulation feasibility studies.
2. Determine degradation impurities produced during stress studies.
3. Develop, validate, and transfer analytical methods.
4. Perform spiking studies during process R&D to demonstrate depletion upon recrystallization.
5. Record retention times and/or spectra
6. Determine relative response factors.
7. Identify unknown impurities that formed during ICH stability conditions.
8. Identify impurities that are present in the Reference Listed Drug
9. Test for and profile impurities not listed in drug substance and drug product monographs.
Analysis Note
These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.
Other Notes
Sales restrictions may apply.
USP issued SDS can be found here

Specifications

General

UNSPSC Code	12352200
MDL number	MFCD00149892
NACRES	NA.24
grade	pharmaceutical analytical impurity (PAI)
agency	USP
API family	levofloxacin
manufacturer/tradename	USP
application(s)	pharmaceutical small molecule
format	neat
storage temp.	2-8°C

Ordering

Notice

Unless otherwise stated, the minimum order amount is USD 1,000.
For orders below USD 1,000, an additional handling fee may apply, or we may arrange local delivery / local handover where available.
All quotations are subject to final confirmation, including product availability, lead time, batch information, shipping cost, and applicable export or handling requirements.
For quotation requests, please send an RFQ from website or contact:

[email protected]

Please send inquiries directly to us in the “To” field. Emails sent via BCC, mass mailing, or with unrelated recipients may be automatically filtered and will not be processed.